Cumberland Settles 2 Patent Suits Over Generic Acetadote

Law360, New York (November 14, 2012, 6:13 PM EST) -- Cumberland Pharmaceuticals Inc. has settled two patent infringement lawsuits against drugmakers Perrigo Co. and Paddock Laboratories LLC, which attempted to market a generic version of its acetaminophen-overdose treatment Acetadote.

Cumberland announced the settlement Monday in a Form 8-K filing with the U.S. Securities and Exchange Commission, in which the company stated that Perrigo and Paddock agreed not to challenge its Acetadote patent. Perrigo acquired Minneapolis-based Paddock in July. The terms of the settlement call for Perrigo to launch a generic version of Acetadote upon the patent's...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.